SREBF2 and prostate cancer: Among them, prostate cancer, gastric cancer, colorectal cancer, and breast cancer show the most pronounced increase in endogenous cholesterol synthesis, with sustained activation of HMGCR and the transcription factor SREBP2 (17, 18).